In the coming months you will see more and more references to Rhofade. When a new rosacea treatment launches everyone wants to know what is it ? Asking this question makes sense as we normally only find out the name of a product right at the end of the development process.
What we now know at Rhofade first became know to Rosacea News as an “over-the-counter drug known to possess vasoconstrictive properties” ie. oxymetazoline back in 2007. So it has been quite a few years from then to now when this active molecule from an over the counter drug
So what is Rhofade?
Rhofade is Oxymetazoline HCL 1% Cream for the Redness of Rosacea.
Allergan has confirmed that Rhofade will be the product name for their soon to be approved Oxymetazoline based treatment for the redness of rosacea.
Oxymetazoline is a sympathomimetic agonist that is selective for the α1A-adrenoceptor over other α1-adrenoceptors and non-selective for the α2-adrenoceptors.
As such, oxymetazoline is a potent vasoconstrictor of the cutaneous microvasculature.
What about Azultro?
Well that is my fault. Based on trademark filings, it looked like Allergan has reserved the name Azultro for their rosacea erythema product. This choice looked more and more unlikely, though as the domain name for azultro.com has laid unclaimed. Rhofade’s .com site is parked ready and waiting
Cutest Rosacea Product Name Ever?
Don’t you agree that Rhofade is a cute name for a product that wants to fade your rosacea redness?
Update: RHOFADE has been approved by the FDA
Now that RHOFADE has been approved we know how Allergen is going to describe RHOFADE as a product.
RHOFADE (oxymetazoline hydrochloride) cream, 1% is indicated for the topical treatment of persistent facial erythema associated with rosacea in adults.